Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
An overview of planning tools that support Zero Based Budgeting, including templates and calculators to help you map expenses and optimize cash flow.
20,362 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Lucid Group has faced years of volatility, but Saudi backing and a clearer product roadmap could shift the odds. This...
A major institutional stake in TTMI has sparked fresh debates about the stock's risk and reward. This guide breaks do...
This original analysis breaks down First Watch's Q4 2025 results, translating the earnings transcript into practical ...
Tempus AI reported an 83% jump in Q4 revenue to $367 million but failed to hit positive full-year profitability, guid...
The U.S. Treasury proposes a drastic sanction to cut a Swiss bank off from dollar clearing amid suspected Iran and Ru...
Aptos has seen a notable price drop even with multiple upbeat developments. This deep dive explains what’s driving th...
Geopolitical risk in the Middle East is reshaping energy markets. Five high-yield energy stocks offer robust dividend...
AST SpaceMobile faces a pivotal Q4 2025 print after the bell on March 2, 2026, with analysts eyeing a revenue uptick ...
Geopolitical headlines drove a rush to buy the dip, yet the rebound failed to materialize for many investors. The epi...
Midweek markets staged a notable reversal as Nasdaq-led tech names helped spark a Wednesday comeback. This guide expl...
As Baidu surges, a hedge fund’s multi-million bet raises questions about AI, China’s digital economy, and portfolio c...